Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Contin

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Clinical Neuropharmacology|June 5, 2003
Excessive daytime sleepiness and levodopa in Parkinson's disease: polygraphic, placebo-controlled monitoringManuela Contin, Federica Provini, Paolo Martinelli, et al.
Frontiers in Pharmacology|March 22, 2021
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access ProgramManuela Contin, Susan Mohamed, Margherita Santucci, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 29, 2020
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and populationGiovanna Calandra-Buonaura, Luisa Sambati, Francesca Baschieri, et al.
Neurology|July 7, 2017
<i>Mucuna pruriens</i> in Parkinson disease: A double-blind, randomized, controlled, crossover studyRoberto Cilia, Janeth Laguna, Erica Cassani, et al.
Frontiers in Neurology|April 14, 2022
Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic SurveySusan Mohamed, Giovanna Lopane, Loredana Sabattini, et al.
Clinical Neuropharmacology|July 20, 2018
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect RelationshipManuela Contin, Luca Mancinelli, Alessandro Perrone, et al.
Clinical Neuropharmacology|June 11, 2004
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson diseaseManuela Contin, Paolo Martinelli, Mirella Mochi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 4, 2013
Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue?Giovanna Calandra-Buonaura, Pietro Guaraldi, Luisa Sambati, et al.
Journal of Sleep Research|August 25, 2007
Daytime sympathetic hyperactivity in OSAS is related to excessive daytime sleepinessVincenzo Donadio, Rocco Liguori, Roberto Vetrugno, et al.
BMJ Open|December 4, 2021
TELEmedicine for EPIlepsy Care (TELE-EPIC): protocol of a randomised, open controlled non-inferiority clinical trialLaura Licchetta, Marina Trivisano, Elisa Baldin, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Clinical Neuropharmacology|June 5, 2003
Excessive daytime sleepiness and levodopa in Parkinson's disease: polygraphic, placebo-controlled monitoringManuela Contin, Federica Provini, Paolo Martinelli, et al.
Frontiers in Pharmacology|March 22, 2021
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access ProgramManuela Contin, Susan Mohamed, Margherita Santucci, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 29, 2020
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and populationGiovanna Calandra-Buonaura, Luisa Sambati, Francesca Baschieri, et al.
Neurology|July 7, 2017
<i>Mucuna pruriens</i> in Parkinson disease: A double-blind, randomized, controlled, crossover studyRoberto Cilia, Janeth Laguna, Erica Cassani, et al.
Frontiers in Neurology|April 14, 2022
Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic SurveySusan Mohamed, Giovanna Lopane, Loredana Sabattini, et al.
Clinical Neuropharmacology|July 20, 2018
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect RelationshipManuela Contin, Luca Mancinelli, Alessandro Perrone, et al.
Clinical Neuropharmacology|June 11, 2004
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson diseaseManuela Contin, Paolo Martinelli, Mirella Mochi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 4, 2013
Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue?Giovanna Calandra-Buonaura, Pietro Guaraldi, Luisa Sambati, et al.
Journal of Sleep Research|August 25, 2007
Daytime sympathetic hyperactivity in OSAS is related to excessive daytime sleepinessVincenzo Donadio, Rocco Liguori, Roberto Vetrugno, et al.
BMJ Open|December 4, 2021
TELEmedicine for EPIlepsy Care (TELE-EPIC): protocol of a randomised, open controlled non-inferiority clinical trialLaura Licchetta, Marina Trivisano, Elisa Baldin, et al.
Pageof 7